SCHEMBL9612491

SCHEMBL9612491

Cc1nc2ccc(-c3cc(C)c4c(c3)CN(C(=O)N3C5CCC3c3ccccc35)CCO4)cc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 6/20 0.48
▸ HSD11B1 P28845 2/20 0.39
▸ PIK3CG P48736 1/20 0.36
▸ CREBBP Q92793 3/20 0.35
▸ RAB9A P51151 3/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ HCRTR1 O43613 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ STAT1 P42224 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ BCHE P06276 2/20 0.34
▸ ACHE P22303 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6126659 0.89 PIK3CA (0.60) PIK3CAHSD11B1CREBBP
SCHEMBL9612499 0.86 PIK3CA (0.53) PIK3CAPIK3CGCREBBPRAB9ASMN1; SMN2
SCHEMBL9612761 0.86 PIK3CA (0.45) PIK3CAHSD11B1PIK3CGCREBBPHCRTR1
SCHEMBL9612704 0.85 PIK3CA (0.51) PIK3CAHSD11B1CREBBPRAB9ASMN1; SMN2
SCHEMBL9612757 0.85 PIK3CA (0.51) PIK3CAHSD11B1PIK3CGCREBBPFGFR1
SCHEMBL9612731 0.85 PIK3CA (0.48) PIK3CAHSD11B1PIK3CGCREBBPFGFR1
SCHEMBL9612583 0.85 PIK3CA (0.48) PIK3CAHSD11B1PIK3CGCREBBPRAB9A
SCHEMBL9612538 0.85 PIK3CA (0.53) PIK3CAPIK3CGCREBBPRAB9ASMN1; SMN2
SCHEMBL9612578 0.84 PIK3CA (0.46) PIK3CAHSD11B1HCRTR1HCRTR2
SCHEMBL15433948 0.84 PIK3CA (0.53) PIK3CAPIK3CGCREBBPRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140378436-A9 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture EXELIXIS, INC. (US) 2014-12-25 — — US disclosed
US-20140378436-A9 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture EXELIXIS, INC. (US) 2014-12-25 — — US disclosed
US-20140024637-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture EXELIXIS, INC. (US) 2014-01-23 — — US disclosed
US-20140024637-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture EXELIXIS, INC. (US) 2014-01-23 — — US disclosed
WO-2012071509-A2 BENZOXAZEPINES AS INHIBITORS OF P13K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378436-A9 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture MTOR, RICTOR, PIK3CA PIK3CA 3/4885HSD11B1 575/4885PIK3CG 10/4885
US-20140024637-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture MTOR, RICTOR, PIK3CA PIK3CA 3/4885HSD11B1 575/4885PIK3CG 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback